MedTrace Logo

Cost-minimization Analysis of Gastric Cancer Treatments in Hong Kong

NCT01679054 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2024-03-12

Study results available
· View outcomes & findings →

Summary

This is a retrospective cost-minimization analysis study to compare the costs of treatment with EOF vs EOX regimens in patients with gastric cancer (GC) in Hong Kong. Patient baseline characteristics and cost data will be extracted from records and compared.

Conditions

Sponsors & Collaborators

  • Hoffmann-La Roche

    collaborator INDUSTRY

  • Princess Margaret Hospital, Hong Kong

    collaborator OTHER_GOV

  • Pamela Youde Nethersole Eastern Hospital

    collaborator OTHER

  • Vivian Wing Yan Lee

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01679054 on ClinicalTrials.gov